Evaluating a Digital Tool for Supporting Breast Cancer Patients

Evaluating a Digital Tool for Supporting Breast Cancer Patients: A Prospective Randomised Controlled Trial

This is a prospective randomised controlled trial that aims to understand the impact of the OWise breast cancer digital tool in newly diagnosed breast cancer patients. Half the patients will receive the digital tool and half the patients will receive standard information. The study will look at the impact of the digital tool on patient activation, health related quality of life (HRQoL), health status, psychological distress, NHS resource utilisation and health care costs.

Inclusion Criteria:

• female
• adult (age 18 years or over)
• newly diagnosed
• early breast cancer
• first primary cancer diagnosis
• under treatment at one of the participating sites.

Exclusion Criteria:

• have started anti-cancer treatment
• private patients
• unable to read or write in English
• significant cognitive impairment
• poor mental health
• do not have access to the internet
• confirmed metastatic disease